KalshiVerifica disponibilitàKYC richiesto2% di commissioneDati di risoluzione verificatiDiscretamente calibratoAvviso sulla qualità dei datiNessuna attività di trading
Dati al 9 set 2026, 10:30 UTC · criterio pm-quality-3
Probabilità implicita attuale
Above 1025000 0%In testa tra 5 esiti
Qualità del mercato
39 / 100
Bassa qualitàVolume 24h
—
Liquidità
—
Liquidità sconosciutaSpread
4.0 pt
Spread moderatoDati di mercato
Aggiornato 11 minuti fa
13 ago 26, 02:25 UTC5 mar 27, 05:00 UTC
Trend
0%
0%
0%
0%
0%
Mercati Correlati
Domande correlate per il contesto, non un confronto tra contratti equivalenti.
Regole
If Natera, Inc. reports the named outcome tests processed in Q3 2026, then the market resolves to Yes.
Si regola tramite:Fiscal.ai
- Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company.
- All trademarks, logos, and brand names are the property of their respective owners.
Mercati aperti
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.2pt97%
- Yes+0.2pt3%
- Volume totale
- 15,6 Mln €
- Volume 24h
- 20,3K €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+0.6pt4%
- Volume totale
- 1,6 Mln €
- Volume 24h
- 8K €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+4.0pt65%
- September41%
- June28%
- Volume totale
- 84,1K €
POLYMARKETEbola pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volume totale
- 652,6K €
- Volume 24h
- 3,4K €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-4.0pt58%
+2 altri esiti
- Volume totale
- 865,4K €
- Volume 24h
- 3K €
POLYMARKETNew pandemic in 2026?
- No+1.0pt94.1%
- Yes-1.0pt5.9%
- Volume totale
- 915,2K €
- Volume 24h
- 1,2K €
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Will 3 mg THC beverages be federally legal to sell?
- Measles cases in U.S. in 2026?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve CagriSema?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
Domande frequenti
- Quali sono le probabilità attuali per Natera tests processed in Q3?
- Kalshi quota Above 1025000 al 0% al 9 settembre 2026.
- Quando si risolve Natera tests processed in Q3?
- Natera tests processed in Q3 dovrebbe risolversi il 5 marzo 2027.
- Come viene liquidato Natera tests processed in Q3?
- Kalshi liquida questo mercato come segue: If Natera, Inc. reports the named outcome tests processed in Q3 2026, then the market resolves to Yes.